Source: Eur Respir J, 55 (5) 1901921; 10.1183/13993003.01921-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
David M.G. Halpin, Mark T. Dransfield, MeiLan K. Han, C. Elaine Jones, Sally Kilbride, Peter Lange, David A. Lipson, David A. Lomas, Fernando J. Martinez, Steve Pascoe, Dave Singh, Robert Wise, Gerard J. Criner. The effect of exacerbation history on outcomes in the IMPACT trial. Eur Respir J, 55 (5) 1901921; 10.1183/13993003.01921-2019

Member's Comments

No comment yet.

Related content which might interest you: Effect of exacerbation history on response to treatment in the TORCH trial Source: Eur Respir J 2007; 30: Suppl. 51, 356s Year: 2007 Effect of excluding ICU-admission on clinical outcomes in a randomized control trial studying the effect of corticosteroids in patients hospitalized with CAP Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Effects of case management on hospitalisation and exacerbation rate in severe, complex COPD: A randomized controlled trial Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011 The long-term effect of an exercise and diet intervention in asthma patients: a 1-year follow-up on a randomised controlled trial Source: ERJ Open Res, 5 (2) 00032-2019; 10.1183/23120541.00032-2019 Year: 2019 Patterns, predictors and outcomes of asthma control and exacerbations during pregnancy: a prospective cohort study Source: ERJ Open Res 2016 Year: 2016 Cluster randomised controlled trial of the effect of introduction of an acute wheeze/asthma integrated care pathway on patient outcome Source: Eur Respir J 2006; 28: Suppl. 50, 481s Year: 2006 The effect of smoking on the treatment outcome in patients with pulmonary tuberculosis: A prospective cohort study Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011 Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial Source: Eur Respir J, 54 (5) 1802134; 10.1183/13993003.02134-2018 Year: 2019 The coping with asthma study: a randomised controlled trial and economic evaluation of a home-based nurse intervention for adults at risk of adverse asthma outcomes Source: Eur Respir J 2003; 22: Suppl. 45, 536s Year: 2003 Short-term HRQL deterioration during early-phase COPD exacerbation: a prospective Canadian cohort study Source: Eur Respir J 2005; 26: Suppl. 49, 296s Year: 2005 Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma: findings from the PRACTICAL study, a randomised clinical trial Source: Eur Respir J, 55 (4) 1902073; 10.1183/13993003.02073-2019 Year: 2020 Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013 Predictors of long-term smoking cessation in patients with COPD: results from a randomised controlled trial Source: Eur Respir J, 49 (6) 1700561; 10.1183/13993003.00561-2017 Year: 2017 Less is more: the impact of maintenance treatment adherence in severe asthma clinical trials Source: Eur Respir J, 53 (5) 1900599; 10.1183/13993003.00599-2019 Year: 2019 Progression of physical inactivity in COPD patients: the effect of time and climate conditions – a multicentre prospective cohort study Source: International Congress 2019 – Hot topics in pulmonary rehabilitation Year: 2019 One-year follow-up of asthma patients in a randomised controlled trial of high-intensity training. Are there lasting effects? Source: International Congress 2018 – Clinical markers of asthma Year: 2018 A randomised clinical trial to assess the effect of active muscle stimulation on hospitalised patients with COPD exacerbations Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance Year: 2012 Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT? Source: ERJ Open Res 2016: 00055-2016 Year: 2016 Study of clinical presentation and predictors of adverse outcome in patients admitted for acute exacerbation of COPD. Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 A multicenter randomized trial for the effectiveness of structured discharge and follow-up protocol on readmission rate in COPD patients receiving LTOT/NIV: one-year interim analysis. Source: International Congress 2018 – Hot topics in non-invasive ventilation Year: 2018